Urology
Volume 75, Issue 5 , Page 1143, May 2010

Editorial Comment

Departments of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0090-4295(10)00044-0

doi:10.1016/j.urology.2009.12.055

Refers to article:

  • The Use of Zoledronic Acid in Men Receiving Androgen Deprivation Therapy for Prostate Cancer With Severe Osteopenia or Osteoporosis , 19 March 2010

    Steven C. Campbell, Nirmala Bhoopalam, Thomas E. Moritz, Mona Pandya, Padmini Iyer, Peter VanVeldhuizen, Nancy K. Ellis, Lizy Thottapurathu, Harinder Garewal, Stuart R. Warren, Nicholas Friedman, Domenic J. Reda
    Urology May 2010 (Vol. 75, Issue 5, Pages 1138-1143)

Urology
Volume 75, Issue 5 , Page 1143, May 2010

Article Tools